AI Terminal
INTERNATIONAL BIOTECHNOLOGY TST PLC
Director's Dealing • May 11, 2022
5163_dirs_2022-05-11_bec1234d-5aa5-4bf1-8a59-d178b721aaff.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 1802L
Intl. Biotechnology Trust PLC
11 May 2022
11 May 2022
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
(the "Company")
The Company was notified today that Professor Patrick Maxwell, a non-executive Director of the Company, purchased 3,725 Ordinary 25p shares in the capital of the Company at a price of 589.347 pence per Ordinary share. As a result of this purchase, Professor Patrick Maxwell 's aggregate holding of shares in the Company is 3,725 Ordinary shares.
Notification of dealing form
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||
| a) | Name | Patrick Maxwell | |
| 2 | Reason for the notification | ||
| a) | Position/status | Non-Executive Director | |
| b) | Initial notification /Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | International Biotechnology Trust plc | |
| b) | LEI | 213800N1QUJ744P76D11 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument | Ordinary shares | |
| Identification code | GB0004559349 | ||
| b) | Nature of the transaction | Share purchase | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 589.347p | 3,725 | ||
| d) | Aggregated information | Aggregated price | Aggregated volume |
| N/A | N/A | ||
| e) | Date of the transaction | 11 May 2022 | |
| f) | Place of the transaction | London Stock Exchange (XLON) |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBRGDURGBDGDB